Clinical Trial

Compare Hemodynamic Effect of Oxytocin Bolus and Infusion During Cesarean Section Under Spinal Anesthesia

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Oxytocin is routinely used during a cesarean section to promote uterine contraction and prevent postpartum hemorrhage. It is typically administered immediately after delivery of the baby, either as a slow intravenous bolus followed by a continuous infusion or as an infusion alone, depending on clinical protocols. By stimulating the uterine muscles to contract, oxytocin helps reduce blood loss and facilitates uterine involution. Care is taken to avoid rapid high-dose administration, as this may lead to side effects such as hypotension and tachycardia
Trial Details
NCT Number NCT07687355
Lead Sponsor Hayatabad Medical Complex
Conditions Comparing 2 Techniques of iv Oxytocin Causing Hemodynamic Changes
Enrollment 262 participants
Start Date 2026-07-01
Primary Completion 2026-10-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-07